FOURTEAU PATRICK 4
4 · Insys Therapeutics, Inc. · Filed Aug 4, 2017
Insider Transaction Report
Form 4
FOURTEAU PATRICK
Director
Transactions
- Exercise/Conversion
Common Stock
2017-08-04$1.62/sh+10,000$16,200→ 69,682 total - Exercise/Conversion
Stock Option (right to buy)
2017-08-04−10,000→ 63,770 totalExercise: $1.62Exp: 2021-03-27→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- [F2]The option is fully vested